These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12354783)
1. Carriership of a defective tenascin-X gene in steroid 21-hydroxylase deficiency patients: TNXB -TNXA hybrids in apparent large-scale gene conversions. Koppens PF; Hoogenboezem T; Degenhart HJ Hum Mol Genet; 2002 Oct; 11(21):2581-90. PubMed ID: 12354783 [TBL] [Abstract][Full Text] [Related]
2. Congenital Adrenal Hyperplasia and Ehlers-Danlos Syndrome. Marino R; Moresco A; Perez Garrido N; Ramirez P; Belgorosky A Front Endocrinol (Lausanne); 2022; 13():803226. PubMed ID: 35282436 [TBL] [Abstract][Full Text] [Related]
3. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene. Fanis P; Skordis N; Phylactou LA; Neocleous V Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454 [TBL] [Abstract][Full Text] [Related]
4. Novel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency. Coeli FB; Soardi FC; Bernardi RD; de Araújo M; Paulino LC; Lau IF; Petroli RJ; de Lemos-Marini SH; Baptista MT; Guerra-Júnior G; de-Mello MP BMC Med Genet; 2010 Jun; 11():104. PubMed ID: 20587039 [TBL] [Abstract][Full Text] [Related]
5. An unequal crossover event in RCCX modules of the human MHC resulting in the formation of a TNXB/TNXA hybrid and deletion of the CYP21A. Jaatinen T; Chung EK; Ruuskanen O; Lokki ML Hum Immunol; 2002 Aug; 63(8):683-9. PubMed ID: 12121677 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the CYP21A1P pseudogene: indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes. Tsai LP; Cheng CF; Chuang SH; Lee HH Anal Biochem; 2011 Jun; 413(2):133-41. PubMed ID: 21324303 [TBL] [Abstract][Full Text] [Related]
7. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Lee HH Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189 [TBL] [Abstract][Full Text] [Related]
10. Genes and Pseudogenes: Complexity of the RCCX Locus and Disease. Carrozza C; Foca L; De Paolis E; Concolino P Front Endocrinol (Lausanne); 2021; 12():709758. PubMed ID: 34394006 [TBL] [Abstract][Full Text] [Related]
11. Targeted long-read sequencing for comprehensive detection of CYP21A2 mutations in patients with 21-hydroxylase deficiency. Zhang X; Gao Y; Lu L; Cao Y; Zhang W; Sun B; Wu X; Tong A; Chen S; Wang X; Mao J; Nie M J Endocrinol Invest; 2024 Apr; 47(4):833-841. PubMed ID: 37815751 [TBL] [Abstract][Full Text] [Related]
12. Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. Kolli V; Kim H; Rao H; Lao Q; Gaynor A; Milner JD; Merke DP BMC Res Notes; 2019 Oct; 12(1):711. PubMed ID: 31666125 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis and genetic testing strategies for diagnosing 21-hydroxylase deficiency, including CAH-X syndrome. Kim JH; Kim GH; Yoo HW; Choi JH Ann Pediatr Endocrinol Metab; 2023 Jun; 28(2):77-86. PubMed ID: 37401054 [TBL] [Abstract][Full Text] [Related]
14. Mapping of a de novo unequal crossover causing a deletion of the steroid 21-hydroxylase (CYP21A2) gene and a non-functional hybrid tenascin-X (TNXB) gene. Koppens PF; Smeets HJ; de Wijs IJ; Degenhart HJ J Med Genet; 2003 May; 40(5):e53. PubMed ID: 12746407 [No Abstract] [Full Text] [Related]
15. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Rupert KL; Rennebohm RM; Yu CY Exp Clin Immunogenet; 1999; 16(2):81-97. PubMed ID: 10343159 [TBL] [Abstract][Full Text] [Related]
16. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency. Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442 [TBL] [Abstract][Full Text] [Related]
17. Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia. Lee HH Clin Chim Acta; 2013 Mar; 418():37-44. PubMed ID: 23313747 [TBL] [Abstract][Full Text] [Related]
18. The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: quadricuspid aortic valve and other midline defects. Chen W; Kim MS; Shanbhag S; Arai A; VanRyzin C; McDonnell NB; Merke DP Am J Med Genet A; 2009 Dec; 149A(12):2803-8. PubMed ID: 19921645 [TBL] [Abstract][Full Text] [Related]
19. CYP21 and CYP21P variability in steroid 21-hydroxylase deficiency patients and in the general population in the Netherlands. Koppens PF; Hoogenboezem T; Degenhart HJ Eur J Hum Genet; 2000 Nov; 8(11):827-36. PubMed ID: 11093272 [TBL] [Abstract][Full Text] [Related]